Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: chemistry

Insane Micro AI Just Shocked The World: CRUSHED Gemini and DeepSeek (Pure Genius)

Samsung just shocked the entire AI world — a 7-million-parameter model called Tiny Recursive Model (TRM) just out-reasoned billion-parameter giants like Gemini and DeepSeek. Built by Samsung’s Montreal research lab, this microscopic AI loops over its own thoughts, rewrites its answers, and fixes mistakes before you even see them — creating reasoning depth without size. It’s 25,000 times smaller than Gemini 2.5 Pro, yet it beat it on real reasoning benchmarks like ARC-AGI.
Meanwhile, Microsoft built an AI brain for quantum chemistry, Anthropic made an AI that audits other AIs, Liquid AI proved on-device intelligence can actually work, and Meta reinvented multimodal search — all in one insane week.

📩 Brand Deals & Partnerships: [email protected].
✉ General Inquiries: [email protected].

🧠 What You’ll See:
• Samsung’s 7-million-parameter TRM model that crushed Gemini and DeepSeek.
• How recursive thinking lets TRM fix its own mistakes 16 times per answer.
• Microsoft’s new neural model that changes quantum chemistry forever.
• Anthropic’s Petri framework that makes AIs audit each other.
• Liquid AI’s mobile-ready MoE model that runs locally on your phone.
• Meta’s new MetaEmbed system that rewrites multimodal search.

🚨 Why It Matters:
AI progress is no longer about size — it’s about intelligence, efficiency, and control. The smallest model just proved it can outsmart the giants.

#ai #Gemini #DeepSeek

Molecular motors drive new non-invasive cancer therapies

Imagine tiny machines, smaller than a virus, spinning inside cancer cells and rewiring their behavior from within. No surgery, no harsh chemicals, just precision at the molecular level.

Two researchers from the Artie McFerrin Department of Chemical Engineering at Texas A&M University are investigating light-activated molecular motors—nanometer-sized machines that can apply from within cells to target and selectively disrupt cancerous activity.

Chemical engineering professor Dr. Jorge Seminario and postdoctoral associate Dr. Diego Galvez-Aranda have contributed to pioneering research by demonstrating a new frontier in non-invasive cancer therapies. The recently published manuscript in the Journal of the American Chemical Society continues this line of investigation.

What’s The Biochemistry Of Fitness In 80yr Olds?

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

Continue reading “What’s The Biochemistry Of Fitness In 80yr Olds?” | >

A New Class of Drug Created That Fights Aging on a Cellular Level

Scientists continue to explore ways we can live longer and ensure those lives are healthier. A new discovery of note in this field comes from experiments in fission yeast (an organism often used for studies of aging).

Researchers from Queen Mary University of London have been testing a new drug called Rapalink-1, building on an existing immunosuppressant called rapamycin that has been shown to extend the life of cells and rodents. In these new tests, Rapalink-1 extended yeast lifespan to a similar degree as rapamycin.

What’s more, molecular analysis revealed that the drug increased the production of enzymes that convert a compound made by gut bacteria, called agmatine, into a variety of other chemicals.

Quantum fluctuations found hidden beneath classical optical signals in polaritons

When optical materials (molecules or solid-state semiconductors) are embedded in tiny photonic boxes, known as optical microcavities, they form hybrid light-matter states known as polaritons. Most of the optical properties of polaritons under weak illumination can be understood using textbook classical optics. Now researchers from UC San Diego show that this is not the entire story: there are quantum fluctuations lurking underneath the classical signal and they reveal a great deal about the molecules in question.

Their work redefines the foundations of polaritonics by demonstrating that the optical spectra of these light–matter hybrids, long described by classical optics, in fact bear subtle quantum fingerprints.

Exploiting these signatures allows polaritons to act as sensitive probes of their host materials, opening new directions for polaritonic control, precision sensing, and quantum photonic technologies. Beyond optics, these hidden further suggest novel avenues for steering chemical reactivity and advancing polaritonic chemistry.

Tiny engine runs hotter than the sun to probe the frontiers of thermodynamics

Scientists have created the world’s hottest engine running at temperatures hotter than those reached in the sun’s core. The team from King’s College London and collaborators believe their platform could provide an unparalleled understanding of the laws of thermodynamics on a small scale, and provide the foundation for a new, efficient way to compute how proteins fold—the subject of last year’s Nobel Prize in Chemistry.

Outlined in Physical Review Letters, the engine is a very small, microscopic particle suspended at a low pressure using . This electric trap is called a Paul Trap. The researchers can exponentially increase the heat of the trapped particle by applying a noisy voltage to one of the electrodes levitating it.

While traditionally engines have been associated with motors, in science their definition is much simpler—engines convert one form of energy to . Here, that is heat to movement.

Caltech Shatters Record With 6,100-Qubit Quantum Array

The neutral-atom platform appears promising for scaling up quantum computers. To solve some of the toughest challenges in physics, chemistry, and other fields, quantum computers will eventually need extremely large numbers of qubits. Unlike classical bits that can only represent a 0 or a 1, qubits

Experimental drug findings pave way for clinical trial to target cancer’s elusive growth switch

Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS and a key pathway for tumor growth.

Now entering the first clinical trial in humans, if found to be safe and effective, these drugs could be used to treat many different types of cancers while avoiding effects on .

A gene called RAS, which kickstarts cell growth pathways, is mutated in around one in five cancers. Mutated versions of the gene lock the RAS protein in an activated state, telling the cancer cell to keep growing bigger and keep dividing.

Dr. Aliza Apple, Ph.D. — VP, Catalyze360 AI/ML and Global Head, Lilly TuneLab, Eli Lilly

Accelerating Promising Biotech Innovation — Dr. Aliza Apple, Ph.D. — Vice President, Catalyze360 AI/ML and Global Head, Lilly TuneLab, Eli Lilly and Company.

Dr. Aliza Apple, Ph.D. is a Vice President of Catalyze360 AI (https://www.lilly.com/science/partners/catalyze-360 and Global Head of Lilly TuneLab (https://tunelab.lilly.com/) at Eli Lilly where she leads the strategy, build and launch of Lilly’s external-facing AI/ML efforts for drug discovery.

Lilly Catalyze360 represents a comprehensive approach to enabling the early-stage biotech ecosystem, agnostic of the therapeutic area, designed to accelerate emerging and promising science, strategically removing barriers to support biotech innovation.

In her previous role at Lilly, Dr. Apple served as the COO and head of Lilly Gateway Labs West Coast, where she supported the local biotech ecosystem through early engagement and providing tailored offerings to meet their needs.

Prior to Lilly, Dr. Apple served as a co-founder at Santa Ana Bio, a venture-backed precision biologics company focused on autoimmune disease, and as an advisor to the founders of Firefly Biologics.

Continue reading “Dr. Aliza Apple, Ph.D. — VP, Catalyze360 AI/ML and Global Head, Lilly TuneLab, Eli Lilly” | >

Enhancing the industrial relevance of alcohol dehydrogenase enzymes by exploiting their ‘hidden reactivity’

Amides and thioesters are ubiquitous compounds in chemistry, used for the production of medicines, natural products, and advanced materials. Traditionally, their synthesis is a messy business, involving wasteful reagents, toxic metals, or energy-intensive conditions.

/* */